Figure 4
From: Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma
Using combined pathway-based risk (CPBR) score as prognosis predictor, based on the combined risk scores for the three individual pathways, results of survival analysis were shown that overall survival was significantly different between high-risk group and low-risk group in (a) the CAN/DF dataset, (b) the HLM dataset, (c) the UM dataset, (d) the MSK dataset and (e) the validation cohort of GSE14814 (f) the validation cohort of GSE1321, respectively.
